Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1183)
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
19,679
Price
$31.47
Total Value
$619.37K
Shares Held After
25,249
% of Holdings
43.8%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
600
Price
$82.08
Total Value
$49.25K
Shares Held After
44,018
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,679
Price
$81.50
Total Value
$299.85K
Shares Held After
44,618
% of Holdings
7.6%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
122,174
Price
$0.41
Total Value
$50.01K
Shares Held After
125,574
% of Holdings
97.3%
Ainos, Inc. (AIMD)
lee ting-chuan — Director
Shares
109,988
Price
$1.90
Total Value
$208.98K
Shares Held After
807,417
% of Holdings
12.0%
Ainos, Inc. (AIMD)
TSAI CHUN-JUNG — Director
Shares
27,718
Price
$1.87
Total Value
$51.83K
Shares Held After
658,199
% of Holdings
4.0%
Ainos, Inc. (AIMD)
Taiwan Carbon Nano Technology Corp — 10% Owner
Shares
41,000
Price
$2.36
Total Value
$96.76K
Shares Held After
948,925
% of Holdings
4.1%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
37,524
Price
$31.49
Total Value
$1.18M
Shares Held After
25,249
% of Holdings
59.8%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
5,401
Price
$21.18
Total Value
$114.39K
Shares Held After
24,509
% of Holdings
18.1%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
551
Price
$80.71
Total Value
$44.47K
Shares Held After
48,297
% of Holdings
1.1%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
4,500
Price
$80.02
Total Value
$360.11K
Shares Held After
48,848
% of Holdings
8.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,800
Price
$79.39
Total Value
$301.69K
Shares Held After
53,348
% of Holdings
6.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
324
Price
$79.17
Total Value
$25.65K
Shares Held After
57,148
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,730
Price
$78.36
Total Value
$292.27K
Shares Held After
57,472
% of Holdings
6.1%
Krystal Biotech, Inc. (KRYS)
Thomas John Charles — EVP, General Counsel
Shares
642
Price
$302.03
Total Value
$193.90K
Shares Held After
0
% of Holdings
100.0%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
4,000
Price
$6.10
Total Value
$24.40K
Shares Held After
700,000
% of Holdings
0.6%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$239.37
Total Value
$47.87K
Shares Held After
400
% of Holdings
50.0%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,966
Price
$26.78
Total Value
$52.65K
Shares Held After
229,918
% of Holdings
0.8%
Ascendis Pharma A/S (ASND)
BIENAIME JEAN JACQUES — Director
Shares
200
Price
$236.24
Total Value
$47.25K
Shares Held After
200
% of Holdings
100.0%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
2,239
Price
$26.78
Total Value
$59.96K
Shares Held After
150,260
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$578.12
Total Value
$439.37K
Shares Held After
18,876
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,929
Price
$577.13
Total Value
$1.11M
Shares Held After
19,636
% of Holdings
8.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,221
Price
$576.21
Total Value
$703.55K
Shares Held After
21,565
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
809
Price
$575.24
Total Value
$465.37K
Shares Held After
22,786
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
281
Price
$574.13
Total Value
$161.33K
Shares Held After
23,595
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$572.70
Total Value
$251.99K
Shares Held After
23,876
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
860
Price
$571.93
Total Value
$491.86K
Shares Held After
24,316
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
700
Price
$570.92
Total Value
$399.64K
Shares Held After
25,176
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
760
Price
$569.79
Total Value
$433.04K
Shares Held After
25,876
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,040
Price
$568.54
Total Value
$591.28K
Shares Held After
26,636
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
520
Price
$567.36
Total Value
$295.03K
Shares Held After
27,676
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
240
Price
$566.37
Total Value
$135.93K
Shares Held After
28,196
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$564.02
Total Value
$157.93K
Shares Held After
28,436
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
135
Price
$561.21
Total Value
$75.76K
Shares Held After
28,716
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
25
Price
$559.58
Total Value
$13.99K
Shares Held After
28,851
% of Holdings
0.1%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
1,489
Price
$26.78
Total Value
$39.87K
Shares Held After
59,291
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,020
Price
$577.97
Total Value
$589.53K
Shares Held After
40,513
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,620
Price
$577.03
Total Value
$934.80K
Shares Held After
41,533
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$574.57
Total Value
$321.76K
Shares Held After
44,653
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$572.66
Total Value
$343.60K
Shares Held After
45,213
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
717
Price
$571.77
Total Value
$409.96K
Shares Held After
45,813
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
683
Price
$570.84
Total Value
$389.89K
Shares Held After
46,530
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
642
Price
$569.69
Total Value
$365.74K
Shares Held After
47,213
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
958
Price
$568.63
Total Value
$544.75K
Shares Held After
47,855
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$567.42
Total Value
$295.06K
Shares Held After
48,813
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$566.36
Total Value
$181.23K
Shares Held After
49,333
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$564.02
Total Value
$135.37K
Shares Held After
49,653
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$562.16
Total Value
$22.49K
Shares Held After
49,893
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
35
Price
$560.74
Total Value
$19.63K
Shares Held After
49,933
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
45
Price
$560.52
Total Value
$25.22K
Shares Held After
49,968
% of Holdings
0.1%
Showing 1–50 of 1183 transactions (page 1 of 24)